Medication Therapy Management for Texas MediCAID Patients With Asthma and Chronic Obstructive Pulmonary Disease—A Pilot Study
Autor: | Jamie C. Barner, Tatiana Makhinova, Kim Roberson, Sabina O. Nduaguba |
---|---|
Rok vydání: | 2021 |
Předmět: |
medicine.medical_specialty
Medication Therapy Management Pharmacist Pulmonary disease Pilot Projects Community Pharmacy Services Pharmacists Pulmonary Disease Chronic Obstructive 03 medical and health sciences 0302 clinical medicine Medication therapy management medicine Humans Pharmacology (medical) Prospective Studies 030212 general & internal medicine Intensive care medicine Asthma Medication use Medicaid business.industry medicine.disease Texas United States 030228 respiratory system business |
Zdroj: | Journal of Pharmacy Practice. 35:528-535 |
ISSN: | 1531-1937 0897-1900 |
Popis: | Background: Pharmacists can play an important role in providing medication therapy management (MTM) services, which focus on appropriate medication use. This pilot study aimed to describe pharmacists’ MTM service provision, results/outcomes of pharmacists’ recommendations and resolution/acceptance rate among patients with high-risk asthma and/or chronic obstructive pulmonary disease (COPD). Methods: This was a prospective descriptive study of MTM services provided by community pharmacists to Texas Medicaid patients (5-63 years) with “high risk” asthma or COPD. Patients received in-person and telephone consultations that included medication review, asthma control test assessment, and education on adherence and proper medication/device use. Data extracted from MTM software was used to describe: reasons for MTM services, type of pharmacists’ interventions, outcomes of pharmacists’ recommendations and acceptance rate. Results: Twenty-eight pharmacists provided 139 MTM interventions with 63 patients (2.2 interventions per patient). The most frequent intervention reason was complex drug therapy (53.2%), underuse of medication (8.6%), need for drug therapy (8.6%), new or changed prescription therapy (6.5%), and administration technique (5.0%). The resolution rate was 77.7%. Patient and prescriber, respectively, refused recommendation in 12% and 6% of the interventions. Outcomes included comprehensive medication review (46.7%), improved adherence (6.5%), therapeutic success (6.5%), improved administration technique (5.0%), and initiation of new therapy (5.0%). Conclusion: Through the provision of MTM, pharmacists were able to identify and intervene with medication-related problems. These interventions are instrumental in helping patients better manage their asthma/COPD. The high resolution rate was encouraging. Larger scale studies are needed to assess clinical and economic outcomes. |
Databáze: | OpenAIRE |
Externí odkaz: |